While Zepbound causes thyroid C-cell tumors in rats, its unknown whether it causes these tumors in humans, so it should not be used by patients with a personal or family history of medullary thyroid cancer or with multiple endocrine neoplasia syndrome type 2, per the FDA
The latest international consensus has taken rituximab only as an option when patients with AChR MG cannot tolerate other immunosuppressants (Narayanaswami et al., 2021)
Cancer 49 , 96101 (1991)
6e), suggesting a disturbance in mitochondrial ATP generation
Static Scroll Though users typically have their first touchpoint with Shotsy on the App Store, I felt it was important that the web landing page be just as refined to match the new design of the app, especially with upcoming press inquiries and social outreach
The medical term for these treatments is GLP-1 agonists, and they are changing how providers treat Type 2 diabetes and obesity